FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.08.2024 · 327 (2) · G175-G187
DOI: 10.1152/ajpgi.00063.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.08.2024. Verfasst von MaKayla L O'Guinn und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Intestinal Mucosa, Lipopolysaccharides. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Intestinal barrier failure is a hallmark in gut-origin sepsis. We demonstrate that the intestinal barriers of farnesoid-X receptor (FXR) knockout (KO) animals are protected from inflammatory insult using multiple models of acute intestinal inflammation. This protection is due to decreased inflammatory cytokine production and maintenance of tight junctional architecture seen within the KO animals. This is the first report of FXR deletion being protective to the intestinal barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States.
- Division of Pediatric Surgery, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, United States.
- Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, California, United States.
- Department of Biochemistry and Molecular Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, United States.
ORCID-Profile: Christopher P Gayer
Förderung
- NIDDK NIH HHS
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
O'Guinn, M. L., Handler, D. A., Hsieh, J. J., Mallicote, M. U., Feliciano, K., & Gayer, C. P. (2024). FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology, 327(2), G175-G187. https://doi.org/10.1152/ajpgi.00063.2024
Vancouver
O'Guinn ML, Handler DA, Hsieh JJ, Mallicote MU, Feliciano K, Gayer CP. FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;327(2):G175-G187. doi:10.1152/ajpgi.00063.2024
BibTeX
@article{OGuinn2024,
author = {O'Guinn, MaKayla L and Handler, David A and Hsieh, Jonathan J and Mallicote, Michael U and Feliciano, Karina and Gayer, Christopher P},
title = {FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2024},
volume = {327},
number = {2},
pages = {G175--G187},
doi = {10.1152/ajpgi.00063.2024}
}
EUVIMED